Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01797224 · ClinicalTrials.gov registry record

OTIS Cimzia Pregnancy Registry

A clinical trial of Rheumatoid Arthritis and Psoriasis, sponsored by University of California, San Diego.

Active
Registry status
925
Enrollment target
1
Study location

NCT01797224: Active study of Rheumatoid Arthritis and Psoriasis, sponsored by University of California, San Diego.

NCT01797224 is a study of Rheumatoid Arthritis and Psoriasis that is active but no longer recruiting, run by University of California, San Diego. The registered enrollment target is 925 participants, below the 4,686-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01797224, a study of Rheumatoid Arthritis and Psoriasis, is active but no longer recruiting, sponsored by University of California, San Diego.

ACTIVE NOT RECRUITING
Registry status
925 participants
Enrollment target
1
Study location

Study Summary

The purpose of the OTIS Autoimmune Diseases in Pregnancy Study is to monitor planned and unplanned pregnancies exposed to certain medications, to evaluate the possible teratogenic effect of these medications and to follow live born infants for five years after birth. With respect to fetal outcome, it is important to evaluate the spectrum of outcomes that may be relevant to a medication exposure during pregnancy, and these include both easily recognizable defects which are visible at birth, as well as more subtle or delayed defects that may not be readily identifiable without special expertise and observation beyond the newborn period.

Primary Outcome

The primary objective of the study is to evaluate the effect of certain medications when used in the first trimester of pregnancy with respect to major structural birth defects.

Study Locations (1)

California

  • University of California, San Diego - San Diego

Trial Details

FieldValue
Enrollment Target 925 participants
Start Date 2012-03
Est. Completion 2026-03
University of California, San Diego

775 total trials

What the registry record for NCT01797224 still lists

NCT01797224 is an observational study that tracks outcomes without assigning an intervention. The registered 925 participants enrollment target is mid-sized for trials with a published cap, below the 4,686-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (80% lower).

The record links to 5 conditions, with Rheumatoid Arthritis appearing as the primary indexed condition, and to 0 interventions.

NCT01797224 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT01797224 about?

NCT01797224 is a clinical study titled "OTIS Cimzia Pregnancy Registry". The purpose of the OTIS Autoimmune Diseases in Pregnancy Study is to monitor planned and unplanned pregnancies exposed to certain medications, to evaluate the possible teratogenic effect of these medications and to follow live born infants for five years after birth. With respect to fetal outcome, i...

What is the current status of trial NCT01797224?

This trial is currently active not recruiting. The enrollment target is 925 participants. The study started on 2012-03. Estimated completion is 2026-03.

What conditions does trial NCT01797224 study?

This clinical trial studies the following conditions: Rheumatoid Arthritis, Psoriasis, Crohn's Disease, Psoriatic Arthritis, Ankylosing Spondylitis.

Who is sponsoring clinical trial NCT01797224?

This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01797224 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Rheumatoid Arthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01797224's enrollment target sits among peer trials

925 24th of 197 higher than 174 of 197 other Rheumatoid Arthritis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Rheumatoid Arthritis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03995082 · 925 participants · NA

    Breast Cancer Patient Engagement With Patient Reported Outcome Measure Survey

  • NCT05656807 · 924 participants · NA

    Evaluation of Child Care Staff Weight Management Program

  • NCT06082453 · 924 participants · NA

    Modernizing Perinatal Syphilis Testing

  • NCT06378541 · 928 participants · NA

    Smartphone App Enhanced Facilitation Among Veterans in a Mental Health Inpatient Setting (Project HOPE)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01797224, the US trial registry maintained by the National Library of Medicine. NCT01797224 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.